The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid

[1]  R. Taneja,et al.  Dyslipidemia in subclinical hypothyroidism and the effect of thyroxine on lipid profile , 2012, Indian journal of endocrinology and metabolism.

[2]  B. Halliwell.  Free radicals and antioxidants: updating a personal view. , 2012, Nutrition reviews.

[3]  E. Pearce.  Update in lipid alterations in subclinical hypothyroidism. , 2012, The Journal of clinical endocrinology and metabolism.

[4]  M. Usta,et al.  Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism. , 2011, Acta bio-medica : Atenei Parmensis.

[5]  N. Tandon,et al.  Dyslipidemia in subclinical hypothyroidism in an Indian population. , 2011, Clinical biochemistry.

[6]  V. Sachdev,et al.  Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. , 2011, The Journal of clinical endocrinology and metabolism.

[7]  L. Kucharski,et al.  Thyroid hormone—induced haemoglobin changes and antioxidant enzymes response in erythrocytes , 2011, Cell biochemistry and function.

[8]  R. Maranhão,et al.  Lipid metabolism in subclinical hypothyroidism: plasma kinetics of triglyceride-rich lipoproteins and lipid transfers to high-density lipoprotein before and after levothyroxine treatment. , 2011, Thyroid : official journal of the American Thyroid Association.

[9]  M. Elisaf,et al.  Effects of Thyroid Dysfunction on Lipid Profile , 2011, The open cardiovascular medicine journal.

[10]  E. Morrison,et al.  The Role of High-Density Lipoproteins in Reducing the Risk of Vascular Diseases, Neurogenerative Disorders, and Cancer , 2010, Cholesterol.

[11]  Wayne Sodano.  Thyroid dysfunction , 2010, BMJ : British Medical Journal.

[12]  A. Boumendjel,et al.  Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats. , 2010, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[13]  B. Pamuk,et al.  Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism , 2009, Clinical endocrinology.

[14]  U. Feldt-Rasmussen.  Is the treatment of subclinical hypothyroidism beneficial? , 2009, Nature Clinical Practice Endocrinology &Metabolism.

[15]  A. Costa,et al.  Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. , 2008, Translational research : the journal of laboratory and clinical medicine.

[16]  B. Biondi,et al.  The clinical significance of subclinical thyroid dysfunction. , 2008, Endocrine reviews.

[17]  R. Demirtunç,et al.  The effects of simvastatin and levothyroxine on intima-media thickness of the carotid artery in female normolipemic patients with subclinical hypothyroidism: a prospective, randomized-controlled study , 2007, Journal of cardiovascular medicine.

[18]  A. Comlekçi,et al.  Plasma Thiobarbituric Acid-Reactive Substance Levels in Subclinical Hypothyroidism , 2007, Medical Principles and Practice.

[19]  L. Vatten,et al.  The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. , 2007, European journal of endocrinology.

[20]  B. Zhang,et al.  Effect of levothyroxine on total lipid profiles as assessed by analytical capillary isotachophoresis in a patient with hypothyroidism. , 2006, Endocrine journal.

[21]  C. Erem.  Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity , 2006, Clinical endocrinology.

[22]  P. Leedman,et al.  Thyroid dysfunction and serum lipids: a community‐based study , 2005, Clinical endocrinology.

[23]  P. Toth.  High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies. , 2005, The American journal of cardiology.

[24]  D. Rader,et al.  New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport , 2005, Circulation research.

[25]  K. Sung,et al.  Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status. , 2004, Archives of medical research.

[26]  G. Assmann,et al.  Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid – a position paper developed by the European Consensus Panel on HDL-C* , 2004, Current medical research and opinion.

[27]  C. Palombo,et al.  Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. , 2004, The Journal of clinical endocrinology and metabolism.

[28]  A. Abdel-Gayoum,et al.  The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders. , 2004, Experimental and molecular pathology.

[29]  C. Duman,et al.  Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. , 2003, Thyroid : official journal of the American Thyroid Association.

[30]  K. Sung,et al.  Thyroid Dysfunction and Their Relation to Cardiovascular Risk Factors such as Lipid Profile, hsCRP, and Waist Hip Ratio in Korea , 2003, The Korean journal of internal medicine.

[31]  P. Fauré,et al.  Inhibition of in vitro macrophage-induced low density lipoprotein oxidation by thyroid compounds. , 2003, The Journal of endocrinology.

[32]  P. Herer,et al.  Risk factors for cardiovascular disease in women with subclinical hypothyroidism. , 2002, Thyroid : official journal of the American Thyroid Association.

[33]  L. Duntas.  Thyroid disease and lipids. , 2002, Thyroid : official journal of the American Thyroid Association.

[34]  J. Drewe,et al.  TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). , 2001, The Journal of clinical endocrinology and metabolism.

[35]  T. Tzotzas,et al.  Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. , 2000, Thyroid : official journal of the American Thyroid Association.

[36]  N. Powe,et al.  Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. , 2000, The Journal of clinical endocrinology and metabolism.

[37]  P. Ladenson,et al.  When to treat mild hypothyroidism. , 2000, Endocrinology and metabolism clinics of North America.

[38]  G. Canaris,et al.  The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.

[39]  D. Cooper.  Subclinical Thyroid Disease: A Clinician's Perspective , 1998, Annals of Internal Medicine.

[40]  A. Miserez,et al.  Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. , 1997, The Journal of clinical endocrinology and metabolism.

[41]  B. Halliwell,et al.  Antioxidants in human health and disease. , 1996, Annual review of nutrition.

[42]  J. Berliner,et al.  Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. , 1995, The Journal of clinical investigation.

[43]  D. Hood,et al.  Effect of hypothyroidism on the expression of cytochrome c and cytochrome c oxidase in heart and muscle during development , 1995, Molecular and Cellular Biochemistry.

[44]  N. Krinsky.  Mechanism of Action of Biological Antioxidants , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[45]  J. Crapo,et al.  Biology of disease: free radicals and tissue injury. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[46]  Raphael Oliveira Ramos Franco Netto.  SERUM-LIPID LEVELS , 1965 .

[47]  M. Bagatini,et al.  Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism , 2010, Clinical chemistry and laboratory medicine.

[48]  V. Fatourechi.  Subclinical hypothyroidism: an update for primary care physicians. , 2009, Mayo Clinic proceedings.

[49]  V. Fatourechi.  Subclinical Hypothyroidism , 2002, Treatments in endocrinology.

[50]  M. Helfand,et al.  Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians. , 1998, Annals of internal medicine.

[51]  R. Curi,et al.  Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. , 1994, The Journal of endocrinology.

[52]  I. Fridovich.  Superoxide radical: an endogenous toxicant. , 1983, Annual review of pharmacology and toxicology.